BR112022004797A2 - Polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase - Google Patents

Polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase

Info

Publication number
BR112022004797A2
BR112022004797A2 BR112022004797A BR112022004797A BR112022004797A2 BR 112022004797 A2 BR112022004797 A2 BR 112022004797A2 BR 112022004797 A BR112022004797 A BR 112022004797A BR 112022004797 A BR112022004797 A BR 112022004797A BR 112022004797 A2 BR112022004797 A2 BR 112022004797A2
Authority
BR
Brazil
Prior art keywords
tetrahydrocannabinolic acid
thca
optimized
engineered variants
methods
Prior art date
Application number
BR112022004797A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Horwitz
Darren Platt
Jeff Ubersax
Jeff Wong
Original Assignee
Demetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Demetrix Inc filed Critical Demetrix Inc
Publication of BR112022004797A2 publication Critical patent/BR112022004797A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y121/00Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
    • C12Y121/03Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
    • C12Y121/03007Tetrahydrocannabinolic acid synthase (1.21.3.7)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
BR112022004797A 2019-09-18 2020-09-17 Polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase BR112022004797A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962902300P 2019-09-18 2019-09-18
PCT/US2020/051261 WO2021055597A1 (en) 2019-09-18 2020-09-17 Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides

Publications (1)

Publication Number Publication Date
BR112022004797A2 true BR112022004797A2 (pt) 2022-06-21

Family

ID=72744852

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004797A BR112022004797A2 (pt) 2019-09-18 2020-09-17 Polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase

Country Status (9)

Country Link
EP (1) EP4031657A1 (ja)
JP (1) JP2022548904A (ja)
CN (1) CN115038786A (ja)
AU (1) AU2020349513A1 (ja)
BR (1) BR112022004797A2 (ja)
CA (1) CA3152803A1 (ja)
IL (1) IL291328A (ja)
MX (1) MX2022003203A (ja)
WO (1) WO2021055597A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020176547A1 (en) 2019-02-25 2020-09-03 Ginkgo Bioworks, Inc. Biosynthesis of cannabinoids and cannabinoid precursors
WO2023168266A2 (en) * 2022-03-02 2023-09-07 Genomatica, Inc. Flavin-dependent oxidases having cannabinoid synthase activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60335574D1 (de) 2002-10-04 2011-02-10 Du Pont Verfahren zur biologischen herstellung von 1,3-propandiol mit hoher ausbeute
CN102027124B (zh) 2007-12-13 2015-11-25 丹尼斯科美国公司 用于生产异戊二烯的组合物和方法
EP2279251A2 (en) 2008-04-23 2011-02-02 Danisco US Inc. Isoprene synthase variants for improved microbial production of isoprene
ES2716231T3 (es) 2008-07-02 2019-06-11 Danisco Us Inc Procedimientos para producir isopreno
ES2898272T3 (es) * 2017-04-27 2022-03-04 Univ California Microorganismos y métodos para producir cannabinoides y derivados de cannabinoides
US11149291B2 (en) * 2017-07-12 2021-10-19 Biomedican, Inc. Production of cannabinoids in yeast
EP3724322A1 (en) * 2017-12-14 2020-10-21 Medicinal Genomics Corporation Methods and kits for classifying cannabinoid production in cannabis plants
WO2020069214A2 (en) * 2018-09-26 2020-04-02 Demetrix, Inc. Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives

Also Published As

Publication number Publication date
CA3152803A1 (en) 2021-03-25
EP4031657A1 (en) 2022-07-27
IL291328A (en) 2022-05-01
CN115038786A (zh) 2022-09-09
WO2021055597A1 (en) 2021-03-25
MX2022003203A (es) 2022-06-08
AU2020349513A1 (en) 2022-05-05
JP2022548904A (ja) 2022-11-22

Similar Documents

Publication Publication Date Title
BR112021023218A2 (pt) Polipeptídeos sintase de canabinoide otimizados
BR112017022298A2 (pt) geranilgeranil pirofosfato sintase
Caliskan et al. Conditional switch between frameshifting regimes upon translation of dnaX mRNA
BR112022004797A2 (pt) Polipeptídeos otimizados de ácido tetra-hidrocanabinólico (thca) sintase
CA3081446A1 (en) Methods and compositions for polypeptide analysis
BR112017017884A2 (pt) switches transcricionais desencadeados por ligação e métodos de uso dos mesmos
BRPI0611909A2 (pt) biossÍntese aperfeiÇoada de aminoÁcido e metabàlito
ES2531135T3 (es) Fitasas, ácidos nucleicos que las codifican y métodos para su producción y uso
BR112012006501A8 (pt) Polipeptídios e usos dos mesmos
Hoffmann et al. Expanding the archaellum regulatory network–the eukaryotic protein kinases ArnC and ArnD influence motility of Sulfolobus acidocaldarius
CU23791A3 (es) Método para la producción de proteínas y anticuerpos mejorados
BR112018003753A2 (pt) bifidobacterium longum
AR053259A1 (es) Trigo con nuevo almidon y metodo para producirlo
MX2010003055A (es) Nuevas citocinas aviares y secuencias geneticas que las codifican.
BR112018077358A2 (pt) tagatose-6-fosfato fosfatase termoestável inovadora e um método para produzir tagatose com o uso da mesma
BR112016025898A2 (pt) ?drimenol sintases e método para produzir drimenol?
BR112016011095A2 (pt) Sequência de endolisina el188 modificada
BR112021023769A2 (pt) Gene para partenogênese
MX2020001058A (es) Marcadores de fusión para expresión de proteínas recombinantes.
BR112017022076A2 (pt) fusões de mesotelina-variante iii de receptor de fator de crescimento epidérmico e métodos de uso das mesmas
BR112016025905A2 (pt) drimenol sintases ii
BR112012033396A2 (pt) Polipetídeo tendo atividade swollenin e seus usos.
BR112021019032A2 (pt) Vetores de fator h e usos dos mesmos
CO2020000231A2 (es) Composiciones inmunogénicas que comprenden cea muc1 y tert
BR112013004743A2 (pt) polipeptídeo isolado com atividade de endopeptidase, composição, método para produzir o polipeptídeo, preparar um hidrolisado de proteína, e para preparar um hidrolisado de proteína alimentar, e, usos do polipeptídeo ou da composição, e de uma endopeptidase do tipo tripsina derivada de uma bactéria

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]